We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
.png?width=908&height=106&name=Layer_1%20(1).png)
APC explained what's going on with California's Board of Pharmacy and the compounded glutathione firefighters count on.
USA Today focuses on the financial impact of GLP-1s being declared out of shortage ... with some perspective from a couple of APCers.
In an article targeted at C-level healthcare folks, the Advisory Board looks at the (potential) fallout from semaglutide coming off the shortage list.
Not surprisingly, APC was included in all those stories about semaglutide coming out of shortage.
We weighed in on a story of attorneys general seemingly impugning compounding pharmacies.
.png?width=410&height=320&name=image-container%20(1).png)
.png?width=410&height=320&name=image-container%20(2).png)
.png?width=411&height=320&name=image-container%20(3).png)
.png?width=410&height=320&name=image-container%20(4).png)
.png)
.png?width=17&height=16&name=folder%20(1).png){kind=small}
%20Pharma-GS.png)